Japan Atherosclerosis Society (JAS) Guidelines for prevention of atherosclerotic cardiovascular diseases 2022

T Okamura, K Tsukamoto, H Arai, Y Fujioka… - … of Atherosclerosis and …, 2024 - jstage.jst.go.jp
In Japan, a super-aged society, deaths from atherosclerotic cardiovascular disease
(ASCVD), especially cardiac diseases including coronary artery disease (CAD) such as …

Educational inequalities in mortality and their mediators among generations across four decades: nationwide, population based, prospective cohort study based on …

J Lu, C Wu, X Zhang, Y Yang, J Cui, W Xu, L Song… - Bmj, 2023 - bmj.com
Objectives To assess the different educational inequalities in mortality among generations
born between 1940 and 1979 in China, and to investigate the role of socioeconomic …

Participation of women and older participants in randomized clinical trials of lipid-lowering therapies: a systematic review

SU Khan, MZ Khan, CR Subramanian, H Riaz… - JAMA Network …, 2020 - jamanetwork.com
Importance Randomized clinical trials (RCTs) of lipid-lowering therapies form the evidence
base for national and international guidelines. However, concerns exist that women and …

Childhood obesity and cardiovascular disease risk

ST Chung, A Krenek, SN Magge - Current atherosclerosis reports, 2023 - Springer
Abstract Purpose of Review The global epidemic of youth-onset obesity is tightly linked to
the rising burden of cardiometabolic disease across the lifespan. While the link between …

Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A meta-analysis and systematic review of 12 620 736 individuals

J Quek, CH Ng, ASP Tang, N Chew, M Chan… - Endocrine Practice, 2022 - Elsevier
Objective The recent introduction of the term metabolic associated fatty liver disease
(MAFLD) sought to reclassify nonalcoholic fatty liver disease (NAFLD). MAFLD is thought to …

Tobacco use disorder and cardiovascular health

NL Benowitz, E Liakoni - Addiction, 2022 - Wiley Online Library
This narrative review examines the impact of cigarette smoking and the use of other tobacco
and nicotine products on cardiovascular disease. Smoking increases the incidence of both …

Emerging roles of ferroptosis in cardiovascular diseases

K Wang, XZ Chen, YH Wang, XL Cheng, Y Zhao… - Cell death …, 2022 - nature.com
The mechanism of cardiovascular diseases (CVDs) is complex and threatens human health.
Cardiomyocyte death is an important participant in the pathophysiological basis of CVDs …

Lipoprotein (a): Knowns, unknowns and uncertainties

M Ruscica, CR Sirtori, A Corsini, GF Watts… - Pharmacological …, 2021 - Elsevier
Over the last 10 years, there have been advances on several aspects of lipoprotein (a)
which are reviewed in the present article. Since the standard immunoassays for measuring …

Management of blood pressure in patients with chronic kidney disease not receiving dialysis: synopsis of the 2021 KDIGO clinical practice guideline

CRV Tomson, AK Cheung, JFE Mann… - Annals of internal …, 2021 - acpjournals.org
Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical
practice guideline for the management of blood pressure (BP) in patients with chronic kidney …

Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases

C Schiano, G Benincasa, M Franzese… - Pharmacology & …, 2020 - Elsevier
The complex pathobiology underlying cardiovascular diseases (CVDs) has yet to be
explained. Aberrant epigenetic changes may result from alterations in enzymatic activities …